- Home
- OCEAW vs BEATW Comparison
OCEAW vs BEATW Comparison
Compare OCEAW & BEATW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCEAW
- BEATW
- Stock Information
- Founded
- OCEAW N/A
- BEATW 2015
- Country
- OCEAW United States
- BEATW United States
- Employees
- OCEAW 7
- BEATW 20
- Industry
- OCEAW Biotechnology: Pharmaceutical Preparations
- BEATW Retail: Computer Software & Peripheral Equipment
- Sector
- OCEAW Health Care
- BEATW Technology
- Exchange
- OCEAW Nasdaq
- BEATW Nasdaq
- Market Cap
- OCEAW N/A
- BEATW N/A
- IPO Year
- OCEAW 2021
- BEATW N/A
- Fundamental
- Price
- OCEAW $0.03
- BEATW $0.56
- Analyst Decision
- OCEAW
- BEATW
- Analyst Count
- OCEAW 0
- BEATW 0
- Target Price
- OCEAW N/A
- BEATW N/A
- AVG Volume (30 Days)
- OCEAW N/A
- BEATW 4.7K
- Earning Date
- OCEAW N/A
- BEATW 03-14-2025
- Dividend Yield
- OCEAW N/A
- BEATW N/A
- EPS Growth
- OCEAW N/A
- BEATW N/A
- EPS
- OCEAW N/A
- BEATW N/A
- Revenue
- OCEAW N/A
- BEATW N/A
- Revenue This Year
- OCEAW N/A
- BEATW N/A
- Revenue Next Year
- OCEAW N/A
- BEATW N/A
- P/E Ratio
- OCEAW N/A
- BEATW N/A
- Revenue Growth
- OCEAW N/A
- BEATW N/A
- 52 Week Low
- OCEAW N/A
- BEATW $0.50
- 52 Week High
- OCEAW N/A
- BEATW $0.62
- Technical
- Relative Strength Index (RSI)
- OCEAW N/A
- BEATW N/A
- Support Level
- OCEAW N/A
- BEATW N/A
- Resistance Level
- OCEAW N/A
- BEATW N/A
- Average True Range (ATR)
- OCEAW 0.00
- BEATW 0.00
- MACD
- OCEAW 0.00
- BEATW 0.00
- Stochastic Oscillator
- OCEAW 0.00
- BEATW 0.00
About OCEAW Ocean Biomediacal Inc.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.
About BEATW Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.